Life and Death of a Superantigen-reactive Human CD4+ T Cell Clone: Staphylococcal Enterotoxins Induce Death by Apoptosis but Simultaneously Trigger a Proliferative Response in the Presence of HLA-DR+ Antigen-presenting Cells
Overview
Authors
Affiliations
We report that a human CD4+ T cell clone with specificity for staphylococcal enterotoxin (SE) superantigens A, D, and E can respond to SEs in two seemingly opposite ways. In the absence of antigen presenting cells (APC), SEA, D, and E (but not SEB or C1) strongly inhibited in a dose-dependent manner the responsiveness of clone D894/25 to exogenous IL-2. Growth inhibition was due to SE-induced programmed cell death (apoptosis) as shown by propidium iodide staining and the appearance of the characteristic ladder pattern of DNA fragmentation. Apoptotic cell death was accompanied by significant cell lysis after 4 and 8 h as measured in a 51Cr release assay. In contrast (but as expected), a proliferative response of clone D894/25 was triggered by SEA, D, and E in the absence of exogenous IL-2 but presence of HLA class II-positive lymphoblastoid cell line (LCL) as APC. Moreover, the addition of LCL feeder cells partially prevented the suppression of IL-2 responsiveness by SEs. Surprisingly, however, the latter two culture conditions (i.e. presence of LCL feeder cells with or without exogenous IL-2) were associated with similar levels of induced cell death as in the absence of LCL. At the clonal level, these data demonstrate that SE superantigens induce programmed cell death in a fraction (40-50%) of responsive mature T cells, irrespective of the presence or absence of MHC class II-positive APC. We conclude that the proliferative response of clone D894/25 which is triggered by SEs in the presence of APC and absence of IL-2 must originate from the fraction (50-60%) of clone T cells surviving SE-induced cell death.
Activation of Human γδ T Cells: Modulation by Toll-Like Receptor 8 Ligands and Role of Monocytes.
Serrano R, Wesch D, Kabelitz D Cells. 2020; 9(3).
PMID: 32183240 PMC: 7140608. DOI: 10.3390/cells9030713.
Ulett G, Adderson E Curr Immunol Rev. 2008; 2(2):119-141.
PMID: 19081777 PMC: 2600511. DOI: 10.2174/157339506776843033.
Targeting T lymphocytes for immune monitoring and intervention in autoimmune diabetes.
Mallone R, Nepom G Am J Ther. 2005; 12(6):534-50.
PMID: 16280647 PMC: 2760127. DOI: 10.1097/01.mjt.0000178772.54396.38.
Radsak M, Iking-Konert C, Stegmaier S, Andrassy K, Hansch G Immunology. 2000; 101(4):521-30.
PMID: 11122456 PMC: 2327116. DOI: 10.1046/j.1365-2567.2000.00140.x.
Wagner C, Burger A, Radsak M, Blum S, Hug F, Hansch G Immunology. 2000; 99(4):532-9.
PMID: 10792500 PMC: 2327190. DOI: 10.1046/j.1365-2567.2000.00995.x.